keyword
https://read.qxmd.com/read/37664441/early-progression-and-transformation-of-a-splenic-diffuse-red-pulp-small-b-cell-lymphoma-with-notch1-arid2-crebbp-and-tnfrsf14-gene-mutations
#21
Paolo Lopedote, Ahmad Al Nawaiseh, Anita Malek, Garrey Faller, Mariana Hattar, Edward Dow, Olga Kozyreva
Splenic diffuse red pulp small B-cell lymphoma (SDRPL) is a rare entity. Diagnosis is typically achieved with splenectomy and most patients remain in remission after this intervention. Hemoglobin value less than 10 g/dL and NOTCH1, TP53, and MAP2K1 gene mutations at diagnosis have been associated with worse outcome. Progression after splenectomy of SDRPL is possible, although transformation to aggressive lymphoma has rarely been reported. We herein report the case of a patient formerly diagnosed with SDRPL with gene mutations involving CREBBP, NOTCH1, ARID2, and TNFRSF14 who transformed to diffuse large B-cell lymphoma six months after splenectomy...
2023: Leukemia Research Reports
https://read.qxmd.com/read/37371564/dysregulation-of-swi-snf-chromatin-remodelers-in-nsclc-its-influence-on-cancer-therapies-including-immunotherapy
#22
REVIEW
Yijiang Shi, Daniel Sanghoon Shin
Lung cancer is the leading cause of cancer death worldwide. Molecularly targeted therapeutics and immunotherapy revolutionized the clinical care of NSCLC patients. However, not all NSCLC patients harbor molecular targets (e.g., mutated EGFR), and only a subset benefits from immunotherapy. Moreover, we are lacking reliable biomarkers for immunotherapy, although PD-L1 expression has been mainly used for guiding front-line therapeutic options. Alterations of the SWI/SNF chromatin remodeler occur commonly in patients with NSCLC...
June 13, 2023: Biomolecules
https://read.qxmd.com/read/37327699/mutational-landscape-of-swi-snf-complex-genes-reveal-correlation-to-predictive-biomarkers-for-immunotherapy-sensitivity-in-lung-adenocarcinoma-patients
#23
JOURNAL ARTICLE
H Xu, H-C Chen, L Yang, G Yang, L Liang, Y Yang, H Tang, H Bao, X Wu, Y Shao, G An, Y Wang
BACKGROUND: The search for prognostic biomarkers indicating sensitivity to immunotherapy in lung adenocarcinoma patients has zeroed in on genes in the switch/sucrose non-fermentable (SWI/SNF) pathway. The mutational profiles of key genes are not clearly defined, however, and no comparisons have been conducted on whether mutations in the genes involved provide the same predictive value. METHODS: In this study, analysis of clinical factors, tumor mutation burden (TMB), chromosomal instability, and co-alterations was conducted for 4344 lung adenocarcinoma samples...
June 14, 2023: ESMO Open
https://read.qxmd.com/read/37248276/deep-exome-sequencing-identifies-enrichment-of-deleterious-mosaic-variants-in-neurodevelopmental-disorder-genes-and-mitochondrial-trna-regions-in-bipolar-disorder
#24
JOURNAL ARTICLE
Masaki Nishioka, Jun Takayama, Naomi Sakai, An-A Kazuno, Mizuho Ishiwata, Junko Ueda, Takashi Hayama, Kumiko Fujii, Toshiyuki Someya, Shinichi Kuriyama, Gen Tamiya, Atsushi Takata, Tadafumi Kato
Bipolar disorder (BD) is a global medical issue, afflicting around 1% of the population with manic and depressive episodes. Despite various genetic studies, the genetic architecture and pathogenesis of BD have not been fully resolved. Besides germline variants, postzygotic mosaic variants are proposed as new candidate mechanisms contributing to BD. Here, we performed extensive deep exome sequencing (DES, ~300×) and validation experiments to investigate the roles of mosaic variants in BD with 235 BD cases (194 probands of trios and 41 single cases) and 39 controls...
May 30, 2023: Molecular Psychiatry
https://read.qxmd.com/read/37244956/eribulin-inhibits-growth-of-cutaneous-squamous-cell-carcinoma-cell-lines-and-a-novel-patient-derived-xenograft
#25
JOURNAL ARTICLE
Che-Yuan Hsu, Teruki Yanagi, Takuya Maeda, Hiroshi Nishihara, Kodai Miyamoto, Shinya Kitamura, Keiko Tokuchi, Hideyuki Ujiie
Advanced cutaneous squamous cell carcinoma (cSCC) is treated with chemotherapy and/or radiotherapy, but these typically fail to achieve satisfactory clinical outcomes. There have been no preclinical studies to evaluate the effectiveness of eribulin against cSCC. Here, we examine the effects of eribulin using cSCC cell lines and a novel cSCC patient-derived xenograft (PDX) model. In the cSCC cell lines (A431 and DJM-1 cells), eribulin was found to inhibit tumor cell proliferation in vitro as assessed by cell ATP levels...
May 27, 2023: Scientific Reports
https://read.qxmd.com/read/37097610/clinicopathologic-genomic-and-immunophenotypic-landscape-of-atm-mutations-in-non-small-cell-lung-cancer
#26
JOURNAL ARTICLE
Biagio Ricciuti, Arielle Elkrief, Joao Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R Vaz, Malini Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniack, Scott Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Cheng
INTRODUCTION: ATM is the most commonly mutated DNA damage and repair gene in non-small cell lung cancer (NSCLC), however limited characterization has been pursued. METHODS: Clinicopathologic, genomic, and treatment data were collected for 5172 patients with NSCLC tumors which underwent genomic profiling. ATM immunohistochemistry (IHC) was performed on 182 NSCLCs with ATM mutations. Multiplexed immunofluorescence was performed on a subset of 535 samples to examine tumor-infiltrating immune cell subsets...
April 25, 2023: Clinical Cancer Research
https://read.qxmd.com/read/37095322/pbrm1-deficient-pbaf-complexes-target-aberrant-genomic-loci-to-activate-the-nf-%C3%AE%C2%BAb-pathway-in-clear-cell-renal-cell-carcinoma
#27
JOURNAL ARTICLE
Xiaosai Yao, Jing Han Hong, Amrita M Nargund, Michelle Shu Wen Ng, Hong Lee Heng, Zhimei Li, Peiyong Guan, Masahiro Sugiura, Pek Lim Chu, Loo Chien Wang, Xiaofen Ye, James Qu, Xiu Yi Kwek, Jeffrey Chun Tatt Lim, Wen Fong Ooi, Joanna Koh, Zhenxun Wang, You-Fu Pan, Yan Shan Ong, Kiat-Yi Tan, Jian Yuan Goh, Sheng Rong Ng, Luca Pignata, Dachuan Huang, Alexander Lezhava, Su Ting Tay, Minghui Lee, Xun Hui Yeo, Wai Leong Tam, Sun Young Rha, Shang Li, Ernesto Guccione, Andrew Futreal, Jing Tan, Joe Poh Sheng Yeong, Wanjin Hong, Robert Yauch, Kenneth Tou-En Chang, Radoslaw M Sobota, Patrick Tan, Bin Tean Teh
PBRM1 encodes an accessory subunit of the PBAF SWI/SNF chromatin remodeller, and the inactivation of PBRM1 is a frequent event in kidney cancer. However, the impact of PBRM1 loss on chromatin remodelling is not well examined. Here we show that, in VHL-deficient renal tumours, PBRM1 deficiency results in ectopic PBAF complexes that localize to de novo genomic loci, activating the pro-tumourigenic NF-κB pathway. PBRM1-deficient PBAF complexes retain the association between SMARCA4 and ARID2, but have loosely tethered BRD7...
May 2023: Nature Cell Biology
https://read.qxmd.com/read/36927767/cell-type-dependent-regulation-of-pluripotency-and-chromatin-remodeling-genes-by-hydralazine
#28
JOURNAL ARTICLE
Alain Aguirre-Vázquez, Fabiola Castorena-Torres, Beatriz Silva-Ramírez, Katia Peñuelas-Urquides, María Elena Camacho-Moll, Luis A Salazar-Olivo, Iván Velasco, Mario Bermúdez de León
BACKGROUND: The generation of induced pluripotent stem cells has opened the field of study for stem cell research, disease modeling and drug development. However, the epigenetic signatures present in somatic cells make cell reprogramming still an inefficient process. This epigenetic memory constitutes an obstacle in cellular reprogramming. Here, we report the effect of hydralazine (HYD) and valproic acid (VPA), two small molecules with proven epigenetic activity, on the expression of pluripotency genes in adult (aHF) and neonatal (nbHF) human fibroblasts...
March 16, 2023: Stem Cell Research & Therapy
https://read.qxmd.com/read/36926051/hr-her2-de-novo-metastatic-breast-cancer-a-true-peculiar-entity
#29
REVIEW
Rosalba Torrisi, Flavia Jacobs, Chiara Miggiano, Rita De Sanctis, Armando Santoro
De novo metastatic breast cancer (dnMBC) accounts for ~6-10% of all breast cancers and for ~30% of MBC with increasing incidence over time. Hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+ /HER2- ) tumours are the most frequent subtype with a similar incidence to that observed amongst recurrent MBC (rMBC). Higher frequency of PI3KCA and ARID2 mutations and a lower frequency of ESR1 mutations and of genes involved in DNA damage, as compared with rMBC, have been reported in HR+ /HER2- dnMBC; however, these are not correlating with prognosis, whilst tumour mutational burden is inversely correlated with outcome...
2023: Drugs in Context
https://read.qxmd.com/read/36870308/triple-negative-apocrine-carcinomas-toward-a-unified-group-with-shared-molecular-features-and-clinical-behavior
#30
JOURNAL ARTICLE
Christopher J Schwartz, Jeanette Ruiz, Gregory R Bean, Deepika Sirohi, Nancy M Joseph, Elizabeth M Hosfield, Timothy W Jacobs, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krings
Triple-negative apocrine carcinomas (TNACs) are rare breast tumors with limited studies evaluating their molecular characteristics and clinical behavior. We performed a histologic, immunohistochemical, genetic, and clinicopathologic assessment of 42 invasive TNACs (1 with a focal spindle cell component) from 41 patients, 2 pure apocrine ductal carcinomas in situ (A-DCIS), and 1 A-DCIS associated with spindle cell metaplastic carcinoma (SCMBC). All TNACs had characteristic apocrine morphology and expressed androgen receptor (42/42), gross cystic disease fluid protein 15 (24/24), and CK5/6 (16/16)...
May 2023: Modern Pathology
https://read.qxmd.com/read/36841437/loss-of-cdkn2a-b-is-a-molecular-marker-of-high-grade-histology-and-is-associated-with-aggressive-behavior-in-acinic-cell-carcinoma
#31
JOURNAL ARTICLE
Snjezana Dogan, Bin Xu, Satshil Rana, Hui Chen, Ronald A Ghossein, Michael F Berger, Alan L Ho, Nora Katabi
Acinic cell carcinoma (AciCC) is a rare salivary gland cancer with excellent prognosis in most cases. However, a subset of patients will develop distant metastasis and die of disease. Recently, a two-tiered grading scheme in AciCC was proposed to recognize patients at risk for poor outcome. We performed a genetic analysis of AciCC to explore the underlying molecular correlates of the tumor grade and examined PD-L1 expression to identify potential candidates for immunotherapy. A retrospective cohort of 55 patients included 34 high-grade and 21 low-grade AciCCs...
February 23, 2023: Modern Pathology
https://read.qxmd.com/read/36821179/tumoral-intraductal-neoplasms-of-the-bile-ducts-comprise-morphologically-and-genetically-distinct-entities
#32
JOURNAL ARTICLE
Tao Wang, Gokce Askan, Kerem Ozcan, Satshil Rana, Ahmet Zehir, Umeshkumar K Bhanot, Rhonda K Yantiss, Deepthi S Rao, Samuel J Wahl, Pelin Bagci, Serdar Balci, Vinod Balachandran, William R Jarnagin, N Volkan Adsay, David S Klimstra, Olca Basturk
CONTEXT.—: Tumoral (grossly visible) intraductal neoplasms of the bile ducts are still being characterized. OBJECTIVE.—: To investigate their morphologic, immunohistochemical, and molecular features. DESIGN.—: Forty-one cases were classified as gastric-, intestinal-, pancreatobiliary-type intraductal papillary neoplasm (IPN), intraductal oncocytic papillary neoplasm (IOPN), or intraductal tubulopapillary neoplasm (ITPN) on the basis of histology...
February 23, 2023: Archives of Pathology & Laboratory Medicine
https://read.qxmd.com/read/36804751/comprehensive-profiling-of-egfr-mutation-subtypes-reveals-genomic-clinical-associations-in-non-small-cell-lung-cancer-patients-on-first-generation-egfr-inhibitors
#33
JOURNAL ARTICLE
Yongkang Bai, Xiang Liu, Limin Zheng, Song Wang, Junli Zhang, Shi Xiong, Pengfei Zhang, Zichen Jiao, Gefei Zhao, Chu Zhou, Jiaohui Pang, Yang Xu, Qiuxiang Ou, Yuan Mao, Louqian Zhang
Common sensitizing mutations in epidermal growth factor receptor (cEGFR), including exon 19 deletions (19-Del) and exon 21 L858R substitution, are associated with high sensitivity to EGFR-TKIs in NSCLC patients. The treatment for NSCLC patients with uncommon EGFR (uEGFR) mutations remains a subject of debate due to heterogeneity in treatment responses. In this manuscript, the targeted next-generation sequencing (NGS) data of a large cohort of EGFR-mutated NSCLC patients was assessed to elucidate genomic profiles of tumors carrying cEGFR or uEGFR mutations...
February 16, 2023: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/36788061/hepatic-sarcomatoid-carcinoma-is-an-aggressive-hepatic-neoplasm-sharing-common-molecular-features-with-its-conventional-carcinomatous-counterparts
#34
JOURNAL ARTICLE
Naomi Yoshuantari, Yung-Ming Jeng, Jau-Yu Liau, Chia-Hsiang Lee, Jia-Huei Tsai
Hepatic sarcomatoid carcinoma is a rare hepatic tumor with an aggressive clinical behavior and dismal outcome. However, the molecular pathogenesis is incompletely defined. In this study, we analyzed 59 hepatic sarcomatoid carcinomas using targeted next-generation sequencing and immunohistochemistry. A panel of 14 genes commonly mutated in primary liver carcinomas was examined. PD-L1 and loss of expression for switch/sucrose nonfermenting complexes, including BAP1, ARID1A, ARID2, and PBRM1, were detected by immunohistochemistry...
January 2023: Modern Pathology
https://read.qxmd.com/read/36756859/arid2-a-rare-cause-of-coffin-siris-syndrome-a-novel-microdeletion-at-12q12q13-11-causing-severe-short-stature-and-literature-review
#35
JOURNAL ARTICLE
Dan Xia, Shuyun Deng, Chenchen Gao, Xiaojuan Li, Lina Zhang, Xiaoqin Xiao, Xiaofang Peng, Jieming Zhang, Zhanwen He, Zhe Meng, Zulin Liu, Nengtai Ouyang, Liyang Liang
Coffin-Siris syndrome (CSS) 6 is caused by heterozygous pathogenic variants in the AT-rich interaction domain 2 (ARID2) gene on 12q12. Currently, only 26 cases with both detailed clinical and genetic information have been documented in the literature. Microdeletions of the entire ARID2 gene are rare. In this study, we report a 5-year-7-month-old Chinese female who underwent whole-exome sequencing to discover that she had a de novo 1.563 Mb heterozygous copy number loss at 12q12q13.11, involving an entire deletion of ARID2...
February 9, 2023: American Journal of Medical Genetics. Part A
https://read.qxmd.com/read/36752523/circulating-triglycerides-are-associated-with-human-adipose-tissue-dna-methylation-of-genes-linked-to-metabolic-disease
#36
JOURNAL ARTICLE
Tina Rönn, Alexander Perfilyev, Josefine Jönsson, Karl-Fredrik Eriksson, Sine W Jørgensen, Charlotte Brøns, Linn Gillberg, Allan Vaag, Elisabet Stener-Victorin, Charlotte Ling
BACKGROUND: Dysregulation of circulating lipids is a central element for the metabolic syndrome. However, it is not well established whether human subcutaneous adipose tissue is affected by or affect circulating lipids through epigenetic mechanisms. Hence, our aim was to investigate the association between circulating lipids and DNA methylation levels in human adipose tissue. METHODS: DNA methylation and gene expression were analyzed genome-wide in subcutaneous adipose tissue from two different cohorts, including 85 men and 93 women, respectively...
February 8, 2023: Human Molecular Genetics
https://read.qxmd.com/read/36739402/prognostic-value-of-genetic-aberrations-and-tumor-immune-microenvironment-in-primary-acral-melanoma
#37
JOURNAL ARTICLE
Rong Huang, Gaigai Shen, Yu Ren, Kelin Zheng, Jiayu Wang, Yan Shi, Jiani C Yin, Lanqun Qin, Guiying Zhang, Mengke Zhao, Xinyu Su, Luqiao Li, Fufeng Wang, Yang Shao, Baorui Liu, Zhengyun Zou
BACKGROUND: Acral melanoma (AM) is the most common subtype in Chinese melanoma patients with a very poor prognosis. However, our understanding of the disease pathogenesis and molecular landscape is limited by the few studies that have been conducted. Here, we profiled the clinical characteristics, mutational landscapes and tumor immune microenvironment of AM patients to gain insights into disease characteristics and potential treatment strategies. METHODS: A total of 90 AM patients were enrolled and their tissue samples were subjected to next-generation sequencing and multiplexed immunohistochemistry tests...
February 4, 2023: Journal of Translational Medicine
https://read.qxmd.com/read/36736507/whole-exome-sequencing-reveals-genetic-variants-in-low-risk-and-high-risk-neuroblastoma
#38
JOURNAL ARTICLE
Zekiye Altun, Hongling Yuan, Burçin Baran, Safiye Aktaş, Esra Esmeray Sönmez, Can Küçük, Nur Olgun
This study aimed to investigate the genetic aberrations in neuroblastoma (NB) by comparing high and low-risk NB patients by whole-exome sequencing (WES) and to reveal the heterogeneity and association between somatic variants and clinical features. Seven NB patients with available clinical data were included in the study (4 in the low-risk group and 3 in the high-risk group). WES was performed and somatic variants associated with NB genes in the COSMIC database were selected through bioinformatics pipeline analysis...
February 2, 2023: Gene
https://read.qxmd.com/read/36572933/genome-wide-distribution-of-histone-trimethylation-reveals-a-global-impact-of-bisphenol-a-on-telomeric-binding-proteins-and-histone-acetyltransferase-factors-a-pilot-study-with-human-and-in-vitro-data
#39
JOURNAL ARTICLE
Shereen Cynthia D'Cruz, Chunxiang Hao, Martin Labussiere, Vicente Mustieles, Carmen Freire, Louis Legoff, Laura Magnaghi-Jaulin, Alicia Olivas-Martinez, Andrea Rodriguez-Carrillo, Christian Jaulin, Arthur David, Mariana F Fernandez, Fatima Smagulova
OBJECTIVE: To assess the genetic and epigenetic effects promoted by Bisphenol A (BPA) exposure in adolescent males from the Spanish INMA-Granada birth cohort, and in human cells. METHODS: DNA methylation was analysed using MEDIP. Repeat number variation in genomic DNA was evaluated, along with the analysis of H3K4me3 by using chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq). Analyses were performed with material extracted from whole blood of the adolescents, complemented by in vitro assessments of human (HeLa) cells exposed to 10 nM BPA, specifically, immunofluorescence evaluation of protein levels, gene expression analysis and ChIP‒qPCR analysis...
December 26, 2022: Clinical Epigenetics
https://read.qxmd.com/read/36567903/usp2-inhibits-lung-cancer-pathogenesis-by-reducing-arid2-protein-degradation-via-ubiquitination
#40
JOURNAL ARTICLE
Lihuan Zhu, Zhizhong Chen, Tianxing Guo, Wenshu Chen, Lilan Zhao, Lingwen Guo, Xiaojie Pan
BACKGROUND: Ubiquitination is an important regulator in physiological and pathological conditions. Ubiquitin-specific protease 2 (USP2), as a member of the USP family, exhibits oncogenic effects in multiple malignancies. However, the exact role of USP2 has not been well clarified in lung cancer pathogenesis and progression. Therefore, we aimed to further investigate the regulatory roles of USP2 in lung cancer in this study. METHODS: Firstly, immunoprecipitation-Mass Spectrometry (IP-MS), Co-immunoprecipitation (Co-IP), combined with immunofluorescent colocalization method, was conducted for USP2 protein interaction analysis in lung cancer cell lines...
2022: BioMed Research International
keyword
keyword
19371
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.